{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T05:54:11Z","timestamp":1778478851830,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008717","name":"Sylvia and Charles Viertel Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ebiom.2026.106185","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:50:56Z","timestamp":1772128256000},"page":"106185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality"],"prefix":"10.1016","volume":"125","author":[{"given":"Ming Z.M.","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Wragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Murdiyarso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devaki","family":"Pilapitiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-8528","authenticated-orcid":false,"given":"Christopher A.","family":"Gonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-1017","authenticated-orcid":false,"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6483","key":"10.1016\/j.ebiom.2026.106185_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"7830","key":"10.1016\/j.ebiom.2026.106185_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106185_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106185_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses","volume":"5","author":"Bos","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"6452","key":"10.1016\/j.ebiom.2026.106185_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106185_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41541-024-00982-1","article-title":"Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens","volume":"9","author":"Miranda","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.ebiom.2026.106185_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104878","article-title":"Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster","volume":"98","author":"Nolan","year":"2023","journal-title":"EBioMedicine"},{"issue":"692","key":"10.1016\/j.ebiom.2026.106185_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI123366","article-title":"Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem","volume":"129","author":"Tan","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106185_bib10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-021-21665-8","article-title":"Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106185_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101477","article-title":"Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: a first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial","volume":"48","author":"Houser","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ebiom.2026.106185_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101383","article-title":"Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: a randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study)","volume":"46","author":"Hern\u00e1ndez-Bernal","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201254","article-title":"Modulating the quantity of HIV Env-specific CD4 T cell help promotes rare B cell responses in germinal centers","volume":"218","author":"Lee","year":"2021","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106185_bib14","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.4049\/jimmunol.168.8.4001","article-title":"Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope","volume":"168","author":"Sarkar","year":"2002","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106185_bib15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes: adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"72","key":"10.1016\/j.ebiom.2026.106185_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm9644","article-title":"Clonal evolution and TCR specificity of the human T(FH) cell response to Plasmodium falciparum CSP","volume":"7","author":"Wahl","year":"2022","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106185_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163338","article-title":"Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults","volume":"133","author":"Cohen","year":"2023","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106185_bib18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","article-title":"Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19","volume":"26","author":"Juno","year":"2020","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106185_bib19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1073\/pnas.92.5.1779","article-title":"Hindrance of binding to class II major histocompatibility complex molecules by a single amino acid residue contiguous to a determinant leads to crypticity of the determinant as well as lack of response to the protein antigen","volume":"92","author":"Grewal","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106185_bib20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/s41590-023-01597-9","article-title":"Molecular basis for potent B cell responses to antigen displayed on particles of viral size","volume":"24","author":"Brooks","year":"2023","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106185_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41541-022-00547-0","article-title":"CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines","volume":"7","author":"Nelson","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"6728","key":"10.1016\/j.ebiom.2026.106185_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.adi2396","article-title":"Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses","volume":"386","author":"Mallajosyula","year":"2024","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","article-title":"Carbohydrate-protein conjugate vaccines","volume":"9","author":"Ada","year":"2003","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106185_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136653","article-title":"Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation","volume":"5","author":"Kelly","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106185_bib25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106185_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106185_bib27","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.immuni.2022.10.015","article-title":"Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses","volume":"55","author":"Moin","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.immuni.2021.12.015","article-title":"Primary germinal center-resident T follicular helper cells are a physiologically distinct subset of CXCR5(hi)PD-1(hi) T follicular helper cells","volume":"55","author":"Yeh","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2010.07.015","article-title":"Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling","volume":"33","author":"Deenick","year":"2010","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106185_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200650","article-title":"Single-cell lineage mapping of a diverse virus-specific naive CD4 T cell repertoire","volume":"218","author":"Khatun","year":"2021","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106185_bib31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1100853","article-title":"Cutting edge: dendritic cell-restricted antigen presentation initiates the follicular helper T cell program but cannot complete ultimate effector differentiation","volume":"187","author":"Goenka","year":"2011","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106185_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.immuni.2007.07.007","article-title":"Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude","volume":"27","author":"Moon","year":"2007","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106185_bib33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2012.11.020","article-title":"Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype","volume":"38","author":"Baumjohann","year":"2013","journal-title":"Immunity"},{"issue":"43","key":"10.1016\/j.ebiom.2026.106185_bib34","doi-asserted-by":"crossref","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106185_bib35","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41591-024-02944-5","article-title":"High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response","volume":"30","author":"Mentzer","year":"2024","journal-title":"Nat Med"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:52:10Z","timestamp":1776199930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S2352396426000666"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106185","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunodominance is a poor predictor of vaccine-induced T follicular helper cell quality","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106185"}}